BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 7519619)

  • 1. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
    Lokeshwar VB; Fregien N; Bourguignon LY
    J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
    Zhu D; Bourguignon LY
    Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis.
    Lokeshwar VB; Bourguignon LY
    J Biol Chem; 1991 Sep; 266(27):17983-9. PubMed ID: 1833390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
    Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
    J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.
    Zhu D; Bourguignon L
    Oncogene; 1996 Jun; 12(11):2309-14. PubMed ID: 8649770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction.
    Lokeshwar VB; Bourguignon LY
    J Biol Chem; 1992 Nov; 267(31):22073-8. PubMed ID: 1429559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
    Zhu D; Bourguignon LY
    J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR; Neame SJ; Isacke CM
    Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
    Yang B; Yang BL; Savani RC; Turley EA
    EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
    Dougherty GJ; Cooper DL; Memory JF; Chiu RK
    J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
    Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
    J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesive interactions between alternatively spliced CD44 isoforms.
    Droll A; Dougherty ST; Chiu RK; Dirks JF; McBride WH; Cooper DL; Dougherty GJ
    J Biol Chem; 1995 May; 270(19):11567-73. PubMed ID: 7538117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin.
    Bourguignon LY; Lokeshwar VB; He J; Chen X; Bourguignon GJ
    Mol Cell Biol; 1992 Oct; 12(10):4464-71. PubMed ID: 1406635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid receptors.
    Stamenkovic I; Aruffo A
    Methods Enzymol; 1994; 245():195-216. PubMed ID: 7539092
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of hyaluronic acid binding sites in the extracellular domain of CD44.
    Peach RJ; Hollenbaugh D; Stamenkovic I; Aruffo A
    J Cell Biol; 1993 Jul; 122(1):257-64. PubMed ID: 8314845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
    Lesley J; English N; Perschl A; Gregoroff J; Hyman R
    J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.